Predictive Oncology Inc. — Director's Dealing 2016

Apr 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2016-03-31

Reporting Person: Kornberg Joshua (Director, CEO and President, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-31	Stock Option (right to buy)	$0.17	A	29412	Acquired	2026-03-31	Common Stock, $.01 par value (29412)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $.01 par value	6961	Direct
Common Stock, $.01 par value	805982	Indirect
Common Stock, $.01 par value	615281	Indirect

Footnotes

F1: A limited liability company of which the Reporting Person is one of the managers. The Reporting Person disclaims beneficial ownership of such shares, except for those as to which he may have a pecuniary interest therein.

F2: A limited liability company, of which the Reporting Person is a member. The Reporting Person disclaims beneficial ownership of such shares, except for those as to which he may have a pecuniary interest therein.